• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定外膜孔蛋白F(OprF)为铜绿假单胞菌表面补体成分C3结合受体分子。

Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.

作者信息

Mishra Meenu, Ressler Adam, Schlesinger Larry S, Wozniak Daniel J

机构信息

Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, USA.

Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

出版信息

Infect Immun. 2015 Aug;83(8):3006-14. doi: 10.1128/IAI.00081-15. Epub 2015 May 11.

DOI:10.1128/IAI.00081-15
PMID:25964476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4496607/
Abstract

Pseudomonas aeruginosa is a versatile opportunistic pathogen that can cause devastating persistent infections. Complement is a highly conserved pathway of the innate immune system, and its role in the first line of defense against pathogens is widely appreciated. One of the earliest events in the complement cascade is the conversion of C3 to C3a and C3b, the latter typically binds to one or more acceptor molecules on the pathogen surface. We previously demonstrated that complement C3b binding acceptors exist on the P. aeruginosa surface. In the current study, we utilized either C3 polyclonal or C3b monoclonal antibodies in a far-Western technique followed by mass spectroscopy to identify the C3b acceptor molecule(s) on the P. aeruginosa surface. Our data provide evidence that OprF (an outer membrane porin, highly conserved in the Pseudomonadaceae) binds C3b. An oprF-deficient P. aeruginosa strain exhibits reduced C3 deposition compared to the wild type. We observed reduced internalization of oprF-deficient bacteria by neutrophils after opsonization compared with wild-type P. aeruginosa. Heterologous expression of OprF significantly enhanced C3b binding and increased serum-mediated bactericidal effects in complement-susceptible Escherichia coli. Furthermore, the predicted secondary structure of the C-terminal, surface-exposed region of OprF has high structural identity to the OmpA domain of several other Gram-negative bacteria, one of which is known to bind C3b. Therefore, these findings provide new insights into the biology of complement interactions with P. aeruginosa and other Gram-negative bacteria.

摘要

铜绿假单胞菌是一种具有多种致病能力的机会致病菌,可引发破坏性的持续性感染。补体是固有免疫系统中一条高度保守的途径,其在抵御病原体的第一道防线中的作用已得到广泛认可。补体级联反应中最早发生的事件之一是C3转化为C3a和C3b,后者通常会与病原体表面的一个或多个受体分子结合。我们之前证明铜绿假单胞菌表面存在补体C3b结合受体。在本研究中,我们采用远缘Western技术,随后进行质谱分析,利用C3多克隆抗体或C3b单克隆抗体来鉴定铜绿假单胞菌表面的C3b受体分子。我们的数据表明,OprF(一种外膜孔蛋白,在假单胞菌科中高度保守)能结合C3b。与野生型相比,oprF基因缺失的铜绿假单胞菌菌株的C3沉积减少。我们观察到,与野生型铜绿假单胞菌相比,调理后oprF基因缺失的细菌被中性粒细胞内化的能力降低。OprF的异源表达显著增强了C3b结合,并增加了血清介导的对补体敏感的大肠杆菌的杀菌作用。此外,OprF C端表面暴露区域的预测二级结构与其他几种革兰氏阴性菌的OmpA结构域具有高度的结构相似性,其中一种已知能结合C3b。因此,这些发现为补体与铜绿假单胞菌及其他革兰氏阴性菌相互作用的生物学机制提供了新的见解。

相似文献

1
Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.鉴定外膜孔蛋白F(OprF)为铜绿假单胞菌表面补体成分C3结合受体分子。
Infect Immun. 2015 Aug;83(8):3006-14. doi: 10.1128/IAI.00081-15. Epub 2015 May 11.
2
Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii.铜绿假单胞菌重组 N 端外膜孔蛋白(OprF)是一种有前途的疫苗候选物,可预防铜绿假单胞菌和部分鲍曼不动杆菌菌株感染。
Int J Med Microbiol. 2020 Apr;310(3):151415. doi: 10.1016/j.ijmm.2020.151415. Epub 2020 Feb 29.
3
Conservation of the gene for outer membrane protein OprF in the family Pseudomonadaceae: sequence of the Pseudomonas syringae oprF gene.假单胞菌科中外膜蛋白OprF基因的保守性:丁香假单胞菌oprF基因序列
J Bacteriol. 1991 Jan;173(2):768-75. doi: 10.1128/jb.173.2.768-775.1991.
4
Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways.铜绿假单胞菌碱性蛋白酶通过经典途径和凝集素途径阻断补体激活。
J Immunol. 2012 Jan 1;188(1):386-93. doi: 10.4049/jimmunol.1102162. Epub 2011 Nov 30.
5
Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.用OprF表位8-OprI型A和B鞭毛蛋白融合蛋白免疫幼年非洲绿猴可促进产生针对非黏液型铜绿假单胞菌的保护性抗体。
Vaccine. 2009 Nov 12;27(48):6762-9. doi: 10.1016/j.vaccine.2009.08.080. Epub 2009 Sep 8.
6
Factor H-related protein 1 promotes complement-mediated opsonization of .因子 H 相关蛋白 1 促进补体介导的 调理作用。
Front Cell Infect Microbiol. 2024 Mar 6;14:1328185. doi: 10.3389/fcimb.2024.1328185. eCollection 2024.
7
Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen.铜绿假单胞菌的二氢硫辛酰胺脱氢酶是一种表面暴露的免疫逃逸蛋白,可结合补体因子 H 家族的三个成员和纤溶酶原。
J Immunol. 2012 Nov 15;189(10):4939-50. doi: 10.4049/jimmunol.1200386. Epub 2012 Oct 15.
8
Pseudomonas aeruginosa OprF plays a role in resistance to macrophage clearance during acute infection.铜绿假单胞菌 OprF 在急性感染期间抵抗巨噬细胞清除中起作用。
Sci Rep. 2021 Jan 11;11(1):359. doi: 10.1038/s41598-020-79678-0.
9
OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa.OprF/I 疫苗接种血清可抑制人干扰素-γ与铜绿假单胞菌的结合。
Vaccine. 2010 Jun 7;28(25):4119-22. doi: 10.1016/j.vaccine.2010.04.028. Epub 2010 Apr 28.
10
Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformer.影响铜绿假单胞菌 OprF 孔蛋白折叠成单域开放构象的因素。
mBio. 2010 Oct 19;1(4):e00228-10. doi: 10.1128/mBio.00228-10.

引用本文的文献

1
Strain-specific variation in the complement resistome of .……补体抗药组中的菌株特异性变异。 (你提供的原文不完整,我只能根据现有内容翻译到这样。)
Infect Immun. 2025 Sep 9;93(9):e0005525. doi: 10.1128/iai.00055-25. Epub 2025 Aug 11.
2
Subversion of the Complement System by Pseudomonas aeruginosa.铜绿假单胞菌对补体系统的颠覆。
J Bacteriol. 2023 Aug 24;205(8):e0001823. doi: 10.1128/jb.00018-23. Epub 2023 Jul 12.
3
and the Complement System: A Review of the Evasion Strategies.以及补体系统:逃避策略综述
Microorganisms. 2023 Mar 6;11(3):664. doi: 10.3390/microorganisms11030664.
4
Immune Response Modulation by Pseudomonas aeruginosa Persister Cells.铜绿假单胞菌持续生存细胞对免疫反应的调节。
mBio. 2023 Apr 25;14(2):e0005623. doi: 10.1128/mbio.00056-23. Epub 2023 Mar 15.
5
Immune response modulation by persister cells.持留菌细胞对免疫反应的调节
bioRxiv. 2023 Jan 8:2023.01.07.523056. doi: 10.1101/2023.01.07.523056.
6
Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses.细胞毒素:细胞毒性的机制及其对炎症反应的影响。
Cells. 2023 Jan 3;12(1):195. doi: 10.3390/cells12010195.
7
Molecular Mechanisms Involved in Pseudomonas aeruginosa Bacteremia.铜绿假单胞菌菌血症的分子机制。
Adv Exp Med Biol. 2022;1386:325-345. doi: 10.1007/978-3-031-08491-1_12.
8
Salmonella Typhimurium outer membrane protein A (OmpA) renders protection from nitrosative stress of macrophages by maintaining the stability of bacterial outer membrane.鼠伤寒沙门氏菌外膜蛋白 A(OmpA)通过维持细菌外膜的稳定性,使巨噬细胞免受硝化应激的影响。
PLoS Pathog. 2022 Aug 15;18(8):e1010708. doi: 10.1371/journal.ppat.1010708. eCollection 2022 Aug.
9
Endothelial Exosome Plays a Functional Role during Rickettsial Infection.内皮细胞外囊泡在立克次体感染中发挥功能作用。
mBio. 2021 May 11;12(3):e00769-21. doi: 10.1128/mBio.00769-21.
10
: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.一种具有适应性毒力因子武器库的大胆病原体。
Int J Mol Sci. 2021 Mar 18;22(6):3128. doi: 10.3390/ijms22063128.

本文引用的文献

1
Study of the protein complex, pore diameter, and pore-forming activity of the Borrelia burgdorferi P13 porin.伯氏疏螺旋体P13孔蛋白的蛋白质复合物、孔径及成孔活性研究
J Biol Chem. 2014 Jul 4;289(27):18614-24. doi: 10.1074/jbc.M113.539528. Epub 2014 May 13.
2
Neisseria gonorrhoeae PIII has a role on NG1873 outer membrane localization and is involved in bacterial adhesion to human cervical and urethral epithelial cells.淋病奈瑟菌 PIII 在 NG1873 外膜定位中起作用,并参与细菌与人宫颈和尿道上皮细胞的粘附。
BMC Microbiol. 2013 Nov 9;13:251. doi: 10.1186/1471-2180-13-251.
3
Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.孔蛋白 B 通过依赖因子 H 的替代途径抑制作用有助于脑膜炎奈瑟菌的毒力。
mBio. 2013 Oct 15;4(5):e00339-13. doi: 10.1128/mBio.00339-13.
4
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.一项评估铜绿假单胞菌杂交外膜蛋白OprF/I疫苗(IC43)在健康志愿者中安全性和免疫原性的随机、安慰剂对照I期研究。
Hum Vaccin Immunother. 2014;10(1):170-83. doi: 10.4161/hv.26565. Epub 2013 Sep 24.
5
RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.RGD 衣壳修饰增强表达铜绿假单胞菌 OprF 的非人类灵长类腺病毒载体的黏膜保护性免疫。
Clin Exp Immunol. 2013 Aug;173(2):230-41. doi: 10.1111/cei.12101.
6
Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.金黄色葡萄球菌蛋白 Sbi 和 Efb 招募人纤溶酶降解补体 C3 和 C3b。
PLoS One. 2012;7(10):e47638. doi: 10.1371/journal.pone.0047638. Epub 2012 Oct 11.
7
Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.囊性纤维化患儿的炎症和肺功能下降的痰液生物标志物。
Am J Respir Crit Care Med. 2012 Nov 1;186(9):857-65. doi: 10.1164/rccm.201203-0507OC. Epub 2012 Aug 16.
8
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.铜绿假单胞菌 Psl 多糖通过限制补体介导的调理作用来减少中性粒细胞的吞噬作用和氧化反应。
Cell Microbiol. 2012 Jan;14(1):95-106. doi: 10.1111/j.1462-5822.2011.01704.x. Epub 2011 Nov 10.
9
OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa.OprF/I 疫苗接种血清可抑制人干扰素-γ与铜绿假单胞菌的结合。
Vaccine. 2010 Jun 7;28(25):4119-22. doi: 10.1016/j.vaccine.2010.04.028. Epub 2010 Apr 28.
10
Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production.铜绿假单胞菌Psl胞外多糖的遗传和生化分析揭示了多糖合成酶在Psl和脂多糖产生中的重叠作用。
Mol Microbiol. 2009 Aug;73(4):622-38. doi: 10.1111/j.1365-2958.2009.06795.x. Epub 2009 Jul 29.